期刊文献+

非小细胞肺癌中p16/MTS1基因失活及其意义 被引量:1

Inactivation of p16/MTS 1 gene in non small cell cancers and its significance
下载PDF
导出
摘要 目的 :研究抑癌基因p16 /MTS1基因失活与肺癌发生发展的关系。方法 :采用双重PCR和免疫组化技术分析 48例原发性非小细胞肺癌中p16基因存在状态。结果 :2 5例p16蛋白表达阴性 (5 2 1% ) ,其中 14例p16基因第二外显子缺失。有淋巴结转移者和无淋巴结转移者的P16蛋白表达阴性率有显著性差异。p16基因缺失率亦如此。肺鳞癌中p16蛋白表达阴性率显著高于腺癌。结论 :p16基因存在状态与非小细胞肺癌的病理组织学分型有关 。 Purpose:To investigate the genomic status of tumor suppressor gene p16 in primary non small cell lung cancers (NSCLC).Methods:p16 gene was analysed by duplex PCR and immunohistochemistry in 48 primary NSCLC tissues. Results:The negative p16 expression was found in 25 samples (25/48).Twelve cases had deletion in the Exon 2 of p16 gene. There was a statistically significant difference between the NSCLC with lymphnode metastasis and that without lymphnode metastasis.The frequency of negative p16 expression was significantly higher in squamouse cell carcinoma(64.3%) than that in adenocarcinoma(31.3%).Conclusions:Inactivation of p16 gene is related to the histologic types and lymphnode metastasis of NSCLC.
出处 《中国癌症杂志》 CAS CSCD 2000年第1期49-50,58,I002,共4页 China Oncology
关键词 非小细胞肺癌 P16基因 基因缺失 MTS1基因 non small cell lung cancer p16 gene gene deletion
  • 相关文献

参考文献9

  • 1KambA,GruisNA,Weaver-FeldhausJ,etal.Acellcycleregulatorpotentiallyinvolvedingenesisofmanytumortypes[J].Science,1994,264(5157):436-440.
  • 2HayashiN,SugimotoY,TsuchiyaE,etal.SomaticmutationsoftheMIS(mutiplerumorsuppressor)1/CDK4I(cyclin-dependentkinase-4inhibitor)geneinhumanprimarynon-smallcelllungcarcinomas[J].BiochemBiophysResCommun,1994,202(3):1426-1430.
  • 3SerranoM,HannonGJ,BeachD.AnewregulatorymodifyincellcyclecontrolcausingspecificinhibitionofcyclinD/CDK[J].Nature,1993,366(6456):704-770.
  • 4ReedAL,CalffanoJ,CairnsP,etal.Highfrquencyofp16(CDKN2/MTS-2/INK4A)inactivationinheadandnecksquamouscellcarciomas[J].CancerRes,1996,56(16):3630-3633.
  • 5MarchettiA,ButtittaF,PellegriniS,etal.Alterationofp16(MTS1)innode-positivenon-smallcelllungcarcinomas[J].JPathol,1997,181(2):178-182.
  • 6MaesawaC,TamuraG,NishizukaS,etal.InactivationoftheCDKN2genebyhomozygonsdeletionanddenowmethylationisassociatedwithadvancedstatgeesophogealsquamouscellcarcinoma[J].CancerRes,1996,56(17):3875-3878.
  • 7HusJW,HsuSL,ShuJJ,etal.IncreasedNM23:MTS1ratioinverselycorrelatedwithmetastasisbehaviourinhumanlungsquamouscellcarcinoma[J].AnticancerRes,1997,17(1A):407-411.
  • 8MaoL,LeeJS,KurieJM,etal.Clonalgeneticalterationsinthelungsofcurrentandfunnersmokers[J].JNatlCancerInst,1997,89(12):857-862.
  • 9TakeshimaY,NishisakaT,KawanoR,etal.p16/CDKN2geneandp53genealterationinJapanesenon-smokingfemalelungadenccacinoma[J]JpnJCancerRes,1996,87(2):134-140

同被引文献6

  • 1Levesque MA, Costa MD, Spatt EH, et al. Quantitative analysis of p53 protein in non - small cell lung cancer and its prognostic value. Int J Cancer, 1998, 79:494
  • 2LggoR,GatterK,Bartek J.Increased expression of mutant froms of p53 oncogene in primary lung cancer.Lancet,1990,335:675
  • 3Dong Y, Walsh MD, Meguckin MA, et al. Increased expression of cyclin- depent kinase inhibitor 2 gene product p16 in ovarian cancer is associated with progression and unfavourable prognosis. Int J Cancer, 1997, 74(1):57
  • 4陈家坤 吴中亮 雷毅雄.肺癌细胞中p53和K—ras基因点突变的研究[J].卫生研究,1998,27:13-13.
  • 5石开虎,俞颖,周久华,颜林洲.肺癌中多癌基因异常表达的临床研究[J].中国肿瘤临床,2000,27(3):210-212. 被引量:3
  • 6唐录英,苏祖兰,金亦,任泽肪,何丹.肺癌组织p53、c-erbB-2表达及病人血白细胞p53基因突变的研究[J].癌症,2002,21(1):99-100. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部